Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Apple
AAPL
|
+$9.29B |
| 2 |
NVIDIA
NVDA
|
+$1.77B |
| 3 |
Broadcom
AVGO
|
+$1.59B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 5 |
T-Mobile US
TMUS
|
+$1.48B |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$3.16B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.92B |
| 3 |
Amazon
AMZN
|
+$2.22B |
| 4 |
Microsoft
MSFT
|
+$2.14B |
| 5 |
Merck
MRK
|
+$1.72B |
Sector Composition
| 1 | Technology | 24.16% |
| 2 | Healthcare | 19.43% |
| 3 | Financials | 13.51% |
| 4 | Consumer Discretionary | 9.13% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Viemed Healthcare
VMD
$266M
| $1.22M | ﹤0.01% |
+185,944
| New | +$1.22M |
|
1527
Ligand Pharmaceuticals
LGND
$3.23B
| $1.21M | ﹤0.01% |
14,402
+1,854
| +15% | +$156K |
|
1528
First Community Corp
FCCO
$213M
| $1.2M | ﹤0.01% |
69,838
| – | – |
|
1529
Biohaven
BHVN
$1.53B
| $1.2M | ﹤0.01% |
34,695
+6,418
| +23% | +$223K |
|
1530
Cabaletta Bio
CABA
$154M
| $1.19M | ﹤0.01% |
158,809
-849,450
| -84% | -$6.35M |
|
|
THRD
1531
DELISTED
Third Harmonic Bio
THRD
| $1.18M | ﹤0.01% |
90,913
+6,703
| +8% | +$87.1K |
|
1532
International Flavors & Fragrances
IFF
$17B
| $1.17M | ﹤0.01% |
12,309
-697
| -5% | -$66.4K |
|
1533
Kroger
KR
$45B
| $1.17M | ﹤0.01% |
23,390
-5,897
| -20% | -$294K |
|
1534
Innoviva
INVA
$1.29B
| $1.16M | ﹤0.01% |
70,905
+5,296
| +8% | +$86.9K |
|
1535
TG Therapeutics
TGTX
$5.14B
| $1.16M | ﹤0.01% |
65,071
-3,088,522
| -98% | -$54.9M |
|
1536
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $1.16M | ﹤0.01% |
15,000
| – | – |
|
1537
Steris
STE
$24.5B
| $1.16M | ﹤0.01% |
5,270
+461
| +10% | +$101K |
|
1538
iShares MSCI Thailand ETF
THD
$237M
| $1.15M | ﹤0.01% |
+21,262
| New | +$1.15M |
|
1539
Toast
TOST
$23.8B
| $1.15M | ﹤0.01% |
+44,673
| New | +$1.15M |
|
1540
Solventum
SOLV
$12.9B
| $1.15M | ﹤0.01% |
+21,668
| New | +$1.15M |
|
1541
Fulcrum Therapeutics
FULC
$393M
| $1.13M | ﹤0.01% |
182,729
+10,069
| +6% | +$62.4K |
|
1542
Vanguard Small-Cap Value ETF
VBR
$31.7B
| $1.13M | ﹤0.01% |
6,197
| – | – |
|
|
PSTX
1543
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.13M | ﹤0.01% |
387,331
+30,435
| +9% | +$88.9K |
|
1544
MacroGenics
MGNX
$111M
| $1.13M | ﹤0.01% |
265,407
+19,576
| +8% | +$83.2K |
|
1545
Healthpeak Properties
DOC
$12.7B
| $1.12M | ﹤0.01% |
57,364
+7,341
| +15% | +$144K |
|
1546
Supernus Pharmaceuticals
SUPN
$2.57B
| $1.09M | ﹤0.01% |
40,676
+2,958
| +8% | +$79.1K |
|
1547
Kraft Heinz
KHC
$31.8B
| $1.08M | ﹤0.01% |
33,607
-641,943
| -95% | -$20.7M |
|
1548
Mersana Therapeutics
MRSN
$35.1M
| $1.07M | ﹤0.01% |
21,315
-70
| -0.3% | -$3.52K |
|
1549
iShares MSCI UAE ETF
UAE
$164M
| $1.07M | ﹤0.01% |
77,537
+753
| +1% | +$10.4K |
|
1550
C4 Therapeutics
CCCC
$193M
| $1.06M | ﹤0.01% |
229,345
+32,236
| +16% | +$149K |
|